cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339

Author:

Büchel Gabriel E.12345ORCID,Kossatz Susanne6789,Sadique Ahmad6789,Rapta Peter10111213,Zalibera Michal10111213ORCID,Bucinsky Lukas10111213,Komorovsky Stanislav141513ORCID,Telser Joshua161718199ORCID,Eppinger Jörg12345ORCID,Reiner Thomas67896,Arion Vladimir B.2021142223ORCID

Affiliation:

1. Division of Physical Sciences and Engineering

2. KAUST Catalysis Center

3. King Abdullah University of Science and Technology

4. Thuwal 23955-6900

5. Saudi Arabia

6. Department of Radiology

7. Memorial Sloan Kettering Cancer Center

8. New York

9. USA

10. Slovak University of Technology

11. Institute of Physical Chemistry and Chemical Physics

12. 81237 Bratislava

13. Slovakia

14. Institute of Inorganic Chemistry

15. Slovak Academy of Sciences

16. Department of Biological

17. Chemical and Physical Sciences

18. Roosevelt University

19. Chicago

20. University of Vienna

21. Faculty of Chemistry

22. A-1090 Vienna

23. Austria

Abstract

The synthesis and characterization of cis-[OsIVCl4(κN2-1H-indazole)2] and its 1e-reduced analog are reported.

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3